Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial

BACKGROUND: This study describes the effect of TG4010 vaccine on Health related Quality of Life (HRQOL) in patients with stage IIIb and IV non–small-cell lung cancer (NSCLC). METHODS: 148 patients with advanced NSCLC expressing MUC1 were randomly assigned to receive TG4010 plus chemotherapy or chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotonda, Christine, Anota, Amélie, Mercier, Mariette, Bastien, Bérangère, Lacoste, Gisèle, Limacher, Jean-Marc, Quoix, Elisabeth, Bonnetain, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514809/
https://www.ncbi.nlm.nih.gov/pubmed/26207902
http://dx.doi.org/10.1371/journal.pone.0132568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514809/
https://www.ncbi.nlm.nih.gov/pubmed/26207902
http://dx.doi.org/10.1371/journal.pone.0132568

Ejemplares similares